JPS63290808A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JPS63290808A JPS63290808A JP12654087A JP12654087A JPS63290808A JP S63290808 A JPS63290808 A JP S63290808A JP 12654087 A JP12654087 A JP 12654087A JP 12654087 A JP12654087 A JP 12654087A JP S63290808 A JPS63290808 A JP S63290808A
- Authority
- JP
- Japan
- Prior art keywords
- chitosan
- acid
- water
- salt
- antibacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 25
- 229920001661 Chitosan Polymers 0.000 claims abstract description 56
- 150000003839 salts Chemical class 0.000 claims abstract description 31
- 239000002253 acid Substances 0.000 claims abstract description 22
- 239000004480 active ingredient Substances 0.000 claims description 3
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 21
- 239000006210 lotion Substances 0.000 abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 12
- 239000006071 cream Substances 0.000 abstract description 9
- 239000002781 deodorant agent Substances 0.000 abstract description 7
- 230000000172 allergic effect Effects 0.000 abstract description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract description 3
- 206010000496 acne Diseases 0.000 abstract description 3
- 230000001988 toxicity Effects 0.000 abstract description 3
- 231100000419 toxicity Toxicity 0.000 abstract description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 abstract 1
- 238000013019 agitation Methods 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000004332 deodorization Methods 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 210000000214 mouth Anatomy 0.000 abstract 1
- 239000012266 salt solution Substances 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 12
- 239000000126 substance Substances 0.000 description 11
- 239000007864 aqueous solution Substances 0.000 description 10
- 230000001877 deodorizing effect Effects 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 235000010469 Glycine max Nutrition 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000001974 tryptic soy broth Substances 0.000 description 6
- 108010050327 trypticase-soy broth Proteins 0.000 description 6
- 241000193830 Bacillus <bacterium> Species 0.000 description 5
- 244000068988 Glycine max Species 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 239000002453 shampoo Substances 0.000 description 4
- 108010076119 Caseins Proteins 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- -1 gargles Substances 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 229940039696 lactobacillus Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000005189 flocculation Methods 0.000 description 2
- 230000016615 flocculation Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229940066544 lactobacillus sporogenes Drugs 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 108010009004 proteose-peptone Proteins 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- KFZXVMNBUMVKLN-UHFFFAOYSA-N 4-chloro-5-methyl-2-propan-2-ylphenol Chemical compound CC(C)C1=CC(Cl)=C(C)C=C1O KFZXVMNBUMVKLN-UHFFFAOYSA-N 0.000 description 1
- 108091005508 Acid proteases Proteins 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 229940099408 Oxidizing agent Drugs 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 230000000397 acetylating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000012164 animal wax Substances 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 1
- 229960001907 nitrofurazone Drugs 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229960000969 phenyl salicylate Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000012178 vegetable wax Substances 0.000 description 1
- 229920003169 water-soluble polymer Chemical class 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
この発明は、防臭、抗菌効果を発揮する化粧料に関する
。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] This invention relates to a cosmetic that exhibits deodorizing and antibacterial effects.
皮膚用、あるいは、口中用等の化粧料として、抗菌性物
質が配合された、防臭、抗菌効果を目的とするものがあ
る。たとえば、にきび用の化粧水やクリーム、デオドラ
ント剤、うがい剤、清拭用剤等がそれで、用途に応じ、
製品の形態に応じて、種々の抗菌性物質が配合されてい
る。また、化粧料自体の防腐のため、上記以外の化粧料
にも、これら抗菌性物質は配合されることが多い。BACKGROUND ART Some cosmetics for the skin or the mouth contain antibacterial substances and are intended to have deodorizing and antibacterial effects. For example, lotions and creams for acne, deodorants, gargles, cleansing agents, etc.
Various antibacterial substances are blended depending on the form of the product. Furthermore, these antibacterial substances are often blended into cosmetics other than those mentioned above in order to preserve the cosmetics themselves.
抗菌性物質としては、たとえば、オキジドール(過酸化
水素水)、逆性石!(陽イオン活性剤)、クロルチモー
ル、サリチル酸、ザロール(サリチル酸フェニル)、石
炭酸(フェノール)、ニトロフラゾン、ヒノキチオール
、ヘキサクロロフェン、硼酸、硼酸ナトリウム等が一般
的に用いられている。Examples of antibacterial substances include Oxidol (hydrogen peroxide) and Gyakusei Stone! (cation activator), chlorthymol, salicylic acid, zalol (phenyl salicylate), carbolic acid (phenol), nitrofurazone, hinokitiol, hexachlorophene, boric acid, sodium borate, etc. are commonly used.
ところが、上記抗菌性物質は、防臭性、抗菌性とともに
、一般に、大なり小なり人体に対する刺激性、毒性、ア
レルギー性等の副作用を併せ持っており、それが為に、
化粧料を製造する際には、用途、目的等に応じて配合で
きる抗菌性物質の種類、量等が制限される。それととも
に、実際の使用にあたっても注意が必要となる。However, in addition to deodorizing and antibacterial properties, the above-mentioned antibacterial substances generally have side effects such as irritation, toxicity, and allergy to the human body to a greater or lesser extent.
When manufacturing cosmetics, there are restrictions on the type, amount, etc. of antibacterial substances that can be added depending on the use, purpose, etc. At the same time, care must be taken in actual use.
この発明は、上記事情に鑑みて、防臭性、抗菌性が高く
、かつ、刺激性、毒性5アレルギー性等を有していない
ため生体適合性に優れた安全な抗菌性物質が配合された
化粧料を提供することを目的としている。In view of the above circumstances, this invention provides cosmetics containing safe antibacterial substances that are highly biocompatible and highly deodorizing and antibacterial, and are not irritating, toxic, or allergic. The purpose is to provide fees.
上記問題に鑑みて、発明者らは、自然界に存在する抗菌
性物質に着目し、種々の化合物について、その防臭性や
抗菌性と生体適合性との関係を調べた。その結果、キチ
ンから得られるキトサンが、優れた防臭性、抗菌性なら
びに生体適合性を併せ持っていることがわかった。しか
し、このようなキトサンは、通常の状態では水に不溶の
固体であり、そのままの状態では、溶液、エマルション
等種々の形態からなる前記化粧料に応用することが難し
いものであった。そこで、□さらに検討を行った結果、
この発明を完成した。In view of the above problems, the inventors focused on antibacterial substances that exist in nature, and investigated the relationship between the deodorizing properties, antibacterial properties, and biocompatibility of various compounds. As a result, it was found that chitosan obtained from chitin has excellent deodorizing properties, antibacterial properties, and biocompatibility. However, such chitosan is a solid that is insoluble in water in its normal state, and it has been difficult to apply it as it is to the cosmetics in various forms such as solutions and emulsions. Therefore, □As a result of further consideration,
completed this invention.
すなわち、この発明は、キトサンが水溶性酸塩の形で有
効成分として配合されていることを特徴とする化粧料を
要旨としている。That is, the gist of the present invention is a cosmetic composition characterized by containing chitosan as an active ingredient in the form of a water-soluble acid salt.
以下、この発明の化粧料について、詳しく説明する。 The cosmetics of this invention will be explained in detail below.
この発明に用いられるキトサンの水溶性酸塩(以下「キ
トサン塩」と記す)は、エビ、カニ等の甲殻類の甲皮、
きのこ、細菌細胞壁等から得られるキチンを税アセチル
化することで得られるキトサンを、有機酸あるいは無機
酸と反応させることで得られる。The water-soluble acid salt of chitosan (hereinafter referred to as "chitosan salt") used in this invention is the carapace of crustaceans such as shrimp and crabs,
Chitosan is obtained by acetylating chitin obtained from mushrooms, bacterial cell walls, etc., and is obtained by reacting it with an organic or inorganic acid.
キトサンは、一般に、平均分子量が20万以上で、酸に
対する溶解性が低いため、そのままの状態では、酸と充
分に反応させることができない傾向がある。そこで、酸
との反応にあたっては、あらかじめ、キトサンを分子量
10万以下に低分子量化したのち、酸と反応させること
が望ましい。Chitosan generally has an average molecular weight of 200,000 or more and has low solubility in acids, so it tends to be unable to react sufficiently with acids in its original state. Therefore, in the reaction with an acid, it is desirable to lower the molecular weight of chitosan to 100,000 or less in advance and then react with the acid.
もちろん、キトサンは、低分子量化せず、そのまま用い
るようであってもよい。Of course, chitosan may be used as it is without reducing its molecular weight.
キトサンの低分子量化の方法としては、酸化剤を用いた
化学処理法や、パパイン、セルラーゼ。Methods for reducing the molecular weight of chitosan include chemical treatment using oxidizing agents, papain, and cellulase.
酸性プロテアーゼ等の酵素を用いた酵素処理法等が挙げ
られる。Examples include enzyme treatment methods using enzymes such as acid protease.
上記のようなキトサンと反応する酸としては、無機酸、
有機酸のいずれを用いてもよい。無機酸としては塩酸等
が挙げられ、有機酸としては蟻酸、乳酸、酢酸、クエン
酸、グリコール酸、マロン酸、アスコルビン酸、アジピ
ン酸、シュウ酸、プロピオン酸、酒石酸、コハク酸、L
−グルタミン酸、L−アスパラギン酸等が挙げられる。Acids that react with chitosan as mentioned above include inorganic acids,
Any organic acid may be used. Examples of inorganic acids include hydrochloric acid, and examples of organic acids include formic acid, lactic acid, acetic acid, citric acid, glycolic acid, malonic acid, ascorbic acid, adipic acid, oxalic acid, propionic acid, tartaric acid, succinic acid, and L.
-Glutamic acid, L-aspartic acid, etc.
なお、酸として硫酸を用いた場合には、得られるキトサ
ン塩が水溶性でなく水不溶性であり、充分な抗菌作用が
得られない。したがって、この発明の化粧料に配合され
るキトサン塩は、上記各酸との反応物たる水溶性酸塩で
ある必要がある。In addition, when sulfuric acid is used as the acid, the obtained chitosan salt is not water-soluble but water-insoluble, and sufficient antibacterial action cannot be obtained. Therefore, the chitosan salt blended into the cosmetic of the present invention needs to be a water-soluble acid salt that is a reactant with each of the above acids.
これらキトサンと酸とを反応させるには、キトサンの粉
末に酸を加えればよいのであるが、これらのものだけで
は反応が急激に行われたり、所定の反応以外の副反応が
起こる可能性もあるため、通常、これらの反応は、水の
存在下で行われる。In order to react these chitosan and acids, it is sufficient to add acid to the chitosan powder, but if only these substances are used, the reaction may occur rapidly or side reactions other than the intended reaction may occur. Therefore, these reactions are usually carried out in the presence of water.
また、この水は、反応によって生成されるキトサン塩を
所定の濃度の水溶液にするためにも必要となる。Further, this water is also required to make the chitosan salt produced by the reaction into an aqueous solution of a predetermined concentration.
このような水を伴う反応の方法としては、キトサン粉末
を水に分散させ、それをかく拌しつつ酸を加える方法等
があるが、それ以外の方法を用いるようであってもよい
。また、以上のようにしてキトサンと酸とを反応させる
にあたり、キトサンを低分子量化するための前記分解酵
素をもこの反応系に添加し、キトサンの低分子量化と熔
解とを同時に行うこともできる。As a method for such a reaction involving water, there is a method such as dispersing chitosan powder in water and adding an acid while stirring it, but other methods may also be used. In addition, in reacting chitosan with an acid as described above, the degrading enzyme for reducing the molecular weight of chitosan can also be added to the reaction system, thereby reducing the molecular weight of chitosan and melting it at the same time. .
酸の配合量は、この発明では特に限定されないが、キト
サンの遊離アミノ基を中和するに必要な量以上配合する
ことが好ましく、得られるキトサン塩の水溶液のpHが
3〜6の範囲内となる量配合することがより好ましい。The amount of acid to be blended is not particularly limited in the present invention, but it is preferable to blend the acid in an amount greater than or equal to the amount necessary to neutralize the free amino groups of chitosan, and the pH of the resulting aqueous solution of chitosan salt is within the range of 3 to 6. It is more preferable to blend the amount.
上記のようなキトサン塩が配合されるのであれば化粧料
の種類は特に限定されず、この発明は、前述したにきび
用の化粧水やクリーム、デオドラント剤、うがい剤、清
拭用剤等を含む、皮膚用。The type of cosmetic is not particularly limited as long as the above-mentioned chitosan salt is blended, and the present invention includes the above-mentioned acne lotion, cream, deodorant, gargle, cleaning agent, etc. , for skin.
ひげそり用2口中用等、あらゆる化粧料に適用すること
ができる。It can be applied to all kinds of cosmetics, such as two-in-one use for shaving.
これら化粧料としては、たとえば、下記のものが挙げら
れるが、ここに示した以外のものであってもよいことは
、言うまでもない。Examples of these cosmetics include the following, but it goes without saying that other cosmetics than those shown here may also be used.
■ 動植物油脂、動植物ロウ、鉱物性ロウ、炭化水素、
脂肪酸類等の油性成分を含む油性の、あるいは、上記油
性成分にさらに、非イオン性界面活性剤、カチオン性界
面活性剤9両性界面活性剤等の乳化剤が配合された乳状
の、クレンジングクリーム、クレンジングローション、
粘液性化粧水、乳液(乳化性化粧水)、2層式化粧水、
クリーム類、ファンデーション類、デオドラントクリー
ム、ゼリーシャンプー、クリームシャンプー、ひげそり
クリーム等。■ Animal and vegetable oils, animal and vegetable waxes, mineral waxes, hydrocarbons,
Cleansing creams and cleansing creams that are oil-based, including oily components such as fatty acids, or emulsifying agents, such as nonionic surfactants, cationic surfactants, 9 amphoteric surfactants, etc., added to the above oily components. lotion,
Mucilage lotion, emulsion (emulsifying lotion), two-layer lotion,
Creams, foundations, deodorant creams, jelly shampoos, cream shampoos, shaving creams, etc.
■ 水溶性糖類、水溶性高分子化合物等を含む水溶液状
または水性ゲル状の、あるいは、アルコール類を基剤と
するアルコール性の、化粧水、デオドラントローション
、液体シャンプー、ひげそりローション、清拭用ローシ
ョン、うがい剤等。■ Aqueous solution or gel containing water-soluble sugars, water-soluble polymer compounds, etc., or alcohol-based lotion, deodorant lotion, liquid shampoo, shaving lotion, and cleaning lotion. , mouthwash, etc.
■ 粉末状、固形状あるいはペースト状の石鹸類、ハウ
ダーファンデーション、ベビーパウター、制汗パウダー
、粉末シャンプー、歯磨き類等。■ Powdered, solid or paste soaps, howder foundation, baby powder, antiperspirant powder, powdered shampoo, toothpaste, etc.
上記のような化粧料に配合される前記キトサン塩は、そ
の化粧料の形態によって、水溶液の状態のまま配合され
るようであってもよいし、水分を除去し、粉末化して配
合されるようであってもよい。Depending on the form of the cosmetic, the chitosan salt may be blended in the form of an aqueous solution, or it may be blended after removing water and turning it into powder. It may be.
上述した各形態のうち、油性や粉末状のものでは水の存
在が好ましくないため、粉末化したキトサン塩を配合す
るようにする。なお、製法によっては、油性や粉末状で
も、キトサン塩を水溶液のまま配合することもできる。Among the above-mentioned forms, since the presence of water is undesirable in oil-based and powdered forms, powdered chitosan salt is blended. Note that depending on the manufacturing method, chitosan salt can be blended as an aqueous solution, even if it is oil-based or powdered.
その他の形態の際には、キトサン塩は水溶液のまま配合
してもよいが、粉末化したキトサン塩を用いるようであ
ってもよい。その際には、水溶液よりもキトサン塩の濃
度を高められる、と言う利点がある。このようにキトサ
ン塩を粉末化する方法としては、噴霧乾燥、凍結乾燥等
、通常の乾燥方法を通用することができる。In other forms, chitosan salt may be blended as an aqueous solution, but powdered chitosan salt may also be used. In this case, there is an advantage that the concentration of chitosan salt can be higher than that in an aqueous solution. As a method for pulverizing chitosan salt in this manner, ordinary drying methods such as spray drying and freeze drying can be used.
キトサン塩の添加量も、この発明では特に限定されない
が、化粧料に対するキトサン塩の添加量は1重量%以上
であることが好ましい。なぜなら、キトサン塩の添加量
が1重量%未満では、充分な抗菌、防臭効果が得られな
い恐れがあるからである。Although the amount of chitosan salt added is not particularly limited in the present invention, it is preferable that the amount of chitosan salt added to the cosmetic is 1% by weight or more. This is because if the amount of chitosan salt added is less than 1% by weight, sufficient antibacterial and deodorizing effects may not be obtained.
これらキトサン塩の防臭、抗菌効果を調べるため、下記
試験を行った。In order to investigate the deodorizing and antibacterial effects of these chitosan salts, the following tests were conducted.
1重量%酢酸水溶液に1重量%の対象キトサンを溶解し
たときの極限粘度から推定した推定分子量15,000
のキトサンの乳酸塩を、各々0.025〜0.25重量
%含むトリブチケースソイブロス培地(培養液)を作成
した。つぎに、あらかじめ、トリプチケースソイブロス
培地で37℃、2日間培養しておいた、臭気ならびに腐
敗の元となる下記5種類の菌株を、それぞれ、1d当た
りの菌数が100〜1000になるように、前記キトサ
ンの乳酸塩を含むトリプチケースソイブロス培地に接種
した。Estimated molecular weight 15,000 estimated from the intrinsic viscosity when 1% by weight of target chitosan is dissolved in 1% by weight acetic acid aqueous solution
A tributicase soy broth medium (culture solution) containing 0.025 to 0.25% by weight of chitosan lactate was prepared. Next, the following 5 types of bacterial strains that cause odor and spoilage were cultured in Trypticase soy broth medium for 2 days at 37°C until the number of bacteria per 1 d was 100 to 1000. Trypticase soy broth medium containing chitosan lactate was inoculated as described above.
(使用菌株)
Staphylococcus aureusBaci
llus 5ubtilis
Bacillus segateriumLactob
acillus plantalutaLactoba
cillus sporogenesなお、上記各画な
らびに培地は以下のとおり。(Used strain) Staphylococcus aureus Bacillus
llus 5ubtilis Bacillus segaterium Lactob
acillus plantaluta Lactoba
cillus sporogenes Each of the above images and the culture medium are as follows.
・5taphylococcus aureus :
代表的な化膿球菌でブドウ球菌とも呼ばれる。・5taphylococcus aureus:
A typical example of pyogenes is pyogenes, also called staphylococcus.
・Bacillus 5ubtilis :枯草菌、
好気性ないし通性嫌気性菌で空中浮遊菌である。・Bacillus 5ubtilis: Bacillus subtilis,
It is an aerobic or facultative anaerobic bacterium that is airborne.
・Bacillus megaterium :従属
栄養菌の一種で、腐生菌、寄生菌、病原菌、あるいは、
共棲菌などがある。・Bacillus megaterium: A type of heterotrophic bacterium, it is a saprophytic bacterium, a parasitic bacterium, a pathogenic bacterium, or
There are symbiotic bacteria.
・Lactobacillus plantalum
:乳酸桿菌で糖質を乳酸に変える。動物の消化器1口
こう等に多く生息する。・Lactobacillus plantalum
: Converts carbohydrates into lactic acid with Lactobacillus. It often lives in the digestive tract and stomach of animals.
・Lactobacillus sporogenes
:酸敗に関与する菌で悪臭を発して腐敗させる。・Lactobacillus sporogenes
: Bacteria involved in rancidity, which gives off a foul odor and causes rot.
・トリプチケースソイブロス培地:下記成分配合を精製
水11に溶解して形成される。- Trypticase soy broth medium: Formed by dissolving the following ingredient combination in purified water 11.
ポリペプトン(カゼインペプトン) 17gポリペプ
トン(大豆ペプトン)3g
塩化ナトリウム 5gリン酸2
カリウム 2.5gブドウ糖
2.5g・ソイビーンカゼイン
ダイジェスト寒天培地(後述)二下記成分を精製水11
に熔解して形成されるもので、医薬、化粧品の細菌検査
用として用いられる。Polypeptone (casein peptone) 17g Polypeptone (soybean peptone) 3g Sodium chloride 5g Phosphoric acid 2
Potassium 2.5g Glucose
2.5g Soy bean casein digest agar medium (described later) 2. Add the following ingredients to purified water 11.
It is formed by melting into a substance, and is used for bacterial testing of pharmaceuticals and cosmetics.
ポリペプトン(カゼインペプトン) 15gポリペプ
トン(大豆ペプトン) 5g塩化ナトリウム
5g寒天
15g上記菌株が接種されたトリプチケース
ソイブロス培地を30℃で培養し、3日後および7日後
の増殖状況を判定した。判定は、前記ソイビーンカゼイ
ンダイジェスト寒天培地上に上記培地液を塗抹培養し、
使用菌株の凝集性の程度ミならびに、キトサンによる培
地蛋白の凝集性により判断した。また、キトサン無添加
のトリプチケースソイブロス培地をも同様に培養し、結
果を対照とした。Polypeptone (casein peptone) 15g Polypeptone (soybean peptone) 5g Sodium chloride
5g agar
A trypticase soy broth medium inoculated with 15 g of the above strain was cultured at 30°C, and the growth status was determined after 3 and 7 days. The determination is made by smearing and culturing the above medium on the soybean casein digest agar medium,
Judgment was made based on the degree of aggregation of the bacterial strain used and the aggregation of culture medium proteins due to chitosan. In addition, trypticase soy broth medium without the addition of chitosan was similarly cultured, and the results were used as a control.
結果を第1表に示す。なお、第1表の判定記号は、下記
の通り。The results are shown in Table 1. The judgment symbols in Table 1 are as follows.
第1表の結果より、キトサン塩を添加したものは、相対
的に、キトサン塩を添加しなかったものに較べ、これら
菌株の増殖を抑止できることが判った。また、キトサン
塩の添加されたものは臭気も発生せず、高い防臭性のあ
ることも判った。From the results shown in Table 1, it was found that the products to which chitosan salt was added were able to inhibit the growth of these bacterial strains relatively compared to the products to which chitosan salt was not added. It was also found that the products to which chitosan salt was added did not generate any odor and had high odor resistance.
つぎに、この発明の実施例について、比較例と併せて説
明する。Next, examples of the present invention will be described together with comparative examples.
(実施例1〜6.比較例1)
以下に示す各成分のうち、モノステアリン酸グリセリン
からセタノールまでの4成分を80℃で混合熔解させ、
これを同じく80℃に熱した精製水に添加した後ホモジ
ナイザーで乳化し、室温まで冷却して乳液を得た。この
乳液全量に対するキトサンの純分量が第2表に示した値
となるように、キトサンの乳酸塩水溶液(pH5,0,
5重量%水溶液)を加えて試料とした。なお、使用した
キトサン乳酸塩は、極限粘度からの推定分子量1500
0であった。(Examples 1 to 6. Comparative Example 1) Among the components shown below, four components from glyceryl monostearate to cetanol were mixed and melted at 80 ° C.
This was added to purified water heated to 80°C, emulsified using a homogenizer, and cooled to room temperature to obtain a milky lotion. A chitosan lactate aqueous solution (pH 5.0,
5% by weight aqueous solution) was added to prepare a sample. The chitosan lactate used has an estimated molecular weight of 1500 from the intrinsic viscosity.
It was 0.
く成分配合〉
得られた試料を80℃に加熱して滅菌したのち、あらか
じめ、トリプチケースソイブロス培地で37℃、2日間
培養しておいた、臭気ならびに腐敗の元となる下記3種
類の菌株を、それぞれ、11当たりの菌数が1000〜
10000になるように接種した。Ingredient combination> After heating the obtained sample to 80℃ and sterilizing it, we cultured it in advance in trypticase soy broth medium at 37℃ for 2 days. For each strain, the number of bacteria per 11 is 1000 ~
The total number of vaccinations was 10,000.
(使用菌株)
Staphylococcus aureusBaci
llus 5ubtilis
Escherichia coli
なお、上記各画のうち、先の二つは前述したとおりであ
り、Escherichia coliは、En te
robac tariaceae科に属し、ダラム陰性
、無胞子の桿菌で動物に寄生し、腸内細菌群の代表菌で
ある。この菌の存在が汚染度の指標となり、病原菌汚染
の危険性を示す。この種の菌が存在すると皮膚分泌物が
分解されて臭気の発生原因となるため、ダラム陰性の汚
染菌の代表として、ここでテストした。(Used strain) Staphylococcus aureus Bacillus
llus 5ubtilis Escherichia coli Of the above, the first two are as described above, and Escherichia coli is En te
It belongs to the robac tariaceae family, is a Durham-negative, non-sporulating bacillus that parasitizes animals, and is a representative bacterium of the enterobacteria group. The presence of these bacteria serves as an indicator of the degree of contamination, indicating the risk of pathogenic contamination. The presence of this type of bacteria degrades skin secretions and causes odor, so it was tested here as a representative of Durham-negative contaminant bacteria.
これらの試料を30℃で培養し、7日後および30日後
の増殖状況を判定した。判定は、ソイビーンカゼインダ
イジェスト寒天培地上に上記培地液を塗床培養し、使用
菌株の凝集性の程度、ならびに、キトサンによる培地蛋
白の凝集性により判断した。また、乳液の変質を、その
外観の変化で判定し、両者を総合して効果を判定した。These samples were cultured at 30°C, and the growth status was determined after 7 and 30 days. Judgment was made by culturing the above-mentioned medium solution on a soy bean casein digest agar medium and based on the degree of flocculation of the strain used and the flocculation of the medium protein due to chitosan. In addition, the deterioration of the emulsion was determined by the change in its appearance, and the effect was determined by combining both.
結果を第2表に示す。なお、第2表の判定記号は、下記
の通り。The results are shown in Table 2. The judgment symbols in Table 2 are as follows.
第2表の結果より、この発明の化粧料たる実施例1〜6
は、いずれも、比較例1に較べて高い抗菌効果を有し、
皮膚の滅菌作用とそれ自体の防腐作用を併せ持っている
ことが判った。From the results in Table 2, Examples 1 to 6 of the cosmetics of this invention
Both have higher antibacterial effects than Comparative Example 1,
It was found that it has both a sterilizing effect on the skin and its own antiseptic effect.
(実施例7〜10)
下記成分配合からなるデオドラントローションを調整し
、試料溶液とした。(Examples 7 to 10) Deodorant lotions having the following ingredient formulations were prepared and used as sample solutions.
く成分配合〉
以上の実施例7〜10で調整した試料溶液を用い、以下
の試験を行った。Component Blend> The following tests were conducted using the sample solutions prepared in Examples 7 to 10 above.
(試 験)
約20cm四方の大きさの局方ガーゼを四つ折りにした
ものの一方に実施例7〜10の試料溶液を、もう一方に
上記成分配合からキトサン塩のみを除いて作成した対照
溶液を、それぞれ、約ice含むようスプレーしたもの
を用意した。試料溶液がスプレーされたガーゼを10名
の被験者の右腋の下に、対照溶液がスプレーされたガー
ゼを10名の被験者の左膝の下に、それぞれ、紙テープ
で貼り、約12時間後にガーゼに移った体臭の差を本人
が評価した。結果を第3表に示す。(Test) A piece of pharmacopoeia gauze with a size of approximately 20 cm square was folded into four. On one side, the sample solutions of Examples 7 to 10 were placed, and on the other side, a control solution prepared by excluding only the chitosan salt from the above ingredient combination was placed. , each of which was sprayed to contain approximately ice was prepared. The gauze sprayed with the sample solution was applied under the right armpit of 10 subjects, and the gauze sprayed with the control solution was applied below the left knee of 10 subjects with paper tape, and the gauze was transferred to the gauze after about 12 hours. Participants themselves evaluated the differences in body odor. The results are shown in Table 3.
また、試験後、ガーゼの接触していた腋の下を観察した
ところ、いずれのキトサン濃度においても、刺激による
アレルギー症状等は認められなかった。Furthermore, after the test, when the armpits that had been in contact with the gauze were observed, no allergic symptoms due to irritation were observed at any chitosan concentration.
第3表の結果より、この発明の化粧料たる実施例7〜l
Oによれば、僅かに効果の差を認めるものをも含めば、
明らかな防臭効果の得られることが判った。From the results in Table 3, Examples 7 to 1 of the cosmetics of this invention
According to O, including those with slight differences in effectiveness,
It was found that a clear deodorizing effect can be obtained.
この発明の化粧料は、以上のようであり、キトサンが水
溶性酸塩の形で有効成分として配合されてなるものであ
るため、防臭性、抗菌性が高く、かつ、刺激性、毒性、
アレルギー性等を有していないため生体適合性に優れた
安全なものとなっている。As described above, the cosmetic of the present invention contains chitosan as an active ingredient in the form of a water-soluble acid salt, so it has high deodorizing and antibacterial properties, and is free from irritation, toxicity, and
Since it has no allergic properties, it is safe and has excellent biocompatibility.
Claims (2)
されていることを特徴とする化粧料。(1) A cosmetic product characterized by containing chitosan as an active ingredient in the form of a water-soluble acid salt.
である特許請求の範囲第1項記載の化粧料。(2) The cosmetic according to claim 1, wherein the amount of the water-soluble acid salt of chitosan added is 10% by weight or more.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62126540A JP2507425B2 (en) | 1987-05-23 | 1987-05-23 | Cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62126540A JP2507425B2 (en) | 1987-05-23 | 1987-05-23 | Cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63290808A true JPS63290808A (en) | 1988-11-28 |
JP2507425B2 JP2507425B2 (en) | 1996-06-12 |
Family
ID=14937717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62126540A Expired - Fee Related JP2507425B2 (en) | 1987-05-23 | 1987-05-23 | Cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2507425B2 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997016164A1 (en) * | 1995-10-28 | 1997-05-09 | Henkel Kommanditgesellschaft Auf Aktien | Deodorizing preparations containing cationic biopolymers, aluminium hydrochlorate and esterase inhibitors |
EP0803513A1 (en) * | 1994-03-18 | 1997-10-29 | Kao Corporation | Fine porous particle and cosmetic |
US5968488A (en) * | 1996-10-21 | 1999-10-19 | Henkel Kommanditgesellschaft Auf Aktien | Deodorizing preparations containing cationic biopolymers, aluminum hydrochlorate and esterase inhibitors |
EP1106168A1 (en) * | 1999-12-07 | 2001-06-13 | Cognis Corporation | Use of chitosan for making shaving compositions |
JP2002542180A (en) * | 1999-04-20 | 2002-12-10 | バイオテク エイエスエイ | Deodorant preparation |
WO2003068182A1 (en) * | 2002-02-15 | 2003-08-21 | Cognis Deutschland Gmbh & Co. Kg | Deodorizing preparations containing chitosans and/or chitosan derivatives |
US6916465B2 (en) | 2000-03-23 | 2005-07-12 | Cognis Deutschland Gmbh & Co. Kg | Deodorizing preparations containing nanosacle chitosans and/or chitosan derivatives |
JP2005336077A (en) * | 2004-05-25 | 2005-12-08 | Natural Health Labo:Kk | Prophylactic/therapeutic agent for stomatitis |
JP2014533667A (en) * | 2011-11-22 | 2014-12-15 | クラリアント・ファイナンス・(ビーブイアイ)・リミテッド | Use of isosorbide caprylate / caprate in body odor prevention and antiperspirant |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4919040A (en) * | 1972-04-18 | 1974-02-20 | ||
JPS58164601A (en) * | 1982-03-26 | 1983-09-29 | Kohjin Co Ltd | Production of water-soluble chitosan salt |
JPS59139310A (en) * | 1983-01-31 | 1984-08-10 | Shiseido Co Ltd | Emulsified composition |
JPS59152312A (en) * | 1983-02-18 | 1984-08-31 | Lion Corp | Oral cavity composition |
JPS60203602A (en) * | 1983-12-06 | 1985-10-15 | サノフイ | Chitosan 6-sulfate and manufacture |
JPS61254517A (en) * | 1985-05-07 | 1986-11-12 | Shiseido Co Ltd | Skin protecting agent |
JPS62221615A (en) * | 1986-03-19 | 1987-09-29 | Lion Corp | Hair cosmetic composition |
JPS6314714A (en) * | 1986-07-04 | 1988-01-21 | Lion Corp | Detergent composition for false tooth |
-
1987
- 1987-05-23 JP JP62126540A patent/JP2507425B2/en not_active Expired - Fee Related
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4919040A (en) * | 1972-04-18 | 1974-02-20 | ||
JPS58164601A (en) * | 1982-03-26 | 1983-09-29 | Kohjin Co Ltd | Production of water-soluble chitosan salt |
JPS59139310A (en) * | 1983-01-31 | 1984-08-10 | Shiseido Co Ltd | Emulsified composition |
JPS59152312A (en) * | 1983-02-18 | 1984-08-31 | Lion Corp | Oral cavity composition |
JPS60203602A (en) * | 1983-12-06 | 1985-10-15 | サノフイ | Chitosan 6-sulfate and manufacture |
JPS61254517A (en) * | 1985-05-07 | 1986-11-12 | Shiseido Co Ltd | Skin protecting agent |
JPS62221615A (en) * | 1986-03-19 | 1987-09-29 | Lion Corp | Hair cosmetic composition |
JPS6314714A (en) * | 1986-07-04 | 1988-01-21 | Lion Corp | Detergent composition for false tooth |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1078891C (en) * | 1994-03-18 | 2002-02-06 | 花王株式会社 | Fine porous particle and cosmetic thereof |
EP0803513A1 (en) * | 1994-03-18 | 1997-10-29 | Kao Corporation | Fine porous particle and cosmetic |
EP0803513A4 (en) * | 1994-03-18 | 1998-04-08 | Kao Corp | Fine porous particle and cosmetic |
US5770187A (en) * | 1994-03-18 | 1998-06-23 | Kao Corporation | Porous particulate and cosmetic |
WO1997016164A1 (en) * | 1995-10-28 | 1997-05-09 | Henkel Kommanditgesellschaft Auf Aktien | Deodorizing preparations containing cationic biopolymers, aluminium hydrochlorate and esterase inhibitors |
US5968488A (en) * | 1996-10-21 | 1999-10-19 | Henkel Kommanditgesellschaft Auf Aktien | Deodorizing preparations containing cationic biopolymers, aluminum hydrochlorate and esterase inhibitors |
JP2002542180A (en) * | 1999-04-20 | 2002-12-10 | バイオテク エイエスエイ | Deodorant preparation |
EP1106168A1 (en) * | 1999-12-07 | 2001-06-13 | Cognis Corporation | Use of chitosan for making shaving compositions |
US6916465B2 (en) | 2000-03-23 | 2005-07-12 | Cognis Deutschland Gmbh & Co. Kg | Deodorizing preparations containing nanosacle chitosans and/or chitosan derivatives |
WO2003068182A1 (en) * | 2002-02-15 | 2003-08-21 | Cognis Deutschland Gmbh & Co. Kg | Deodorizing preparations containing chitosans and/or chitosan derivatives |
JP2005336077A (en) * | 2004-05-25 | 2005-12-08 | Natural Health Labo:Kk | Prophylactic/therapeutic agent for stomatitis |
JP2014533667A (en) * | 2011-11-22 | 2014-12-15 | クラリアント・ファイナンス・(ビーブイアイ)・リミテッド | Use of isosorbide caprylate / caprate in body odor prevention and antiperspirant |
JP2018052947A (en) * | 2011-11-22 | 2018-04-05 | クラリアント・ファイナンス・(ビーブイアイ)・リミテッド | Use of isosorbide caprylates/caprates in deodorants and antiperspirants |
Also Published As
Publication number | Publication date |
---|---|
JP2507425B2 (en) | 1996-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0934742B1 (en) | Anti-microbial cleansers | |
JPH07330505A (en) | Antimicrobial composition | |
CA2688736C (en) | Novel compositions containing lysozyme and c-1/c-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology | |
KR100541271B1 (en) | Antimicrobial compositions for topical use | |
US10792258B2 (en) | Antiseptic, antiseborrheic and exfoliating composition to remove or prevent acne | |
KR20040033376A (en) | Cosmetics composition comprising sophorolipids | |
CN105658055A (en) | Antimicrobial compositions | |
JPS63290808A (en) | Cosmetic | |
KR20090038648A (en) | A composition using the cosmetic containing chamaecyparis obtusa oil for a pimpled skin | |
CN1322815C (en) | Method for preparing the bactericide and the cleansing facial milk] | |
JP2004307484A (en) | Antiseptic bactericide, and cosmetic, pharmaceutical and foodstuff blended with the same | |
JP4565275B2 (en) | Antibacterial composition | |
EP3723714B1 (en) | Propanediol monoacetate mononitrate | |
JPH04288017A (en) | Treating agent for pimple | |
JPH11199433A (en) | Use of honey as agent to reduce adherence of microbe | |
EP1638516B1 (en) | Barrier formulation comprising a silicone based emulsion | |
WO2019002400A1 (en) | Antimicrobial mixture containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one and an aromatic alcohol, and cosmetic composition containing same | |
KR100513301B1 (en) | A composition for washing foot | |
EP3485869B1 (en) | Use of phytantriol as an antimicrobial agent in the preservation of a composition | |
JP2003113097A (en) | External preparation including aureobasidium culture solution | |
JPH11302147A (en) | Cosmetic | |
CN110831570A (en) | New use | |
JP2018052891A (en) | Liniment for controlling resident skin bacteria | |
JPS62273905A (en) | Cosmetic | |
CN114096229B (en) | Use of dianhydrohexitols for eliminating the effects of acne, dandruff and malodour on the instrumentation of the appearance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |